LIVIVO - Search results -

Search results

Result 1 - 10 of total 4083

Search options

Article ; Online: Effects of S-pindolol in mouse pancreatic and lung cancer cachexia models.

Springer, Jochen / Jové, Queralt / de Lima Junior, Edson Alves / Ladrón, Natalia Álvarez / López-Soriano, Francisco Javier / Busquets, Silvia / Argiles, Josep M / Marks, Daniel L

Journal of cachexia, sarcopenia and muscle

2023 Volume 14, Issue 3, Page(s) 1244–1248

Abstract: Background: It is known that S-pindolol attenuates muscle loss in animal models of cancer cachexia ... function, which is strongly compromised in cachectic animals.: Methods: Here, we tested 3 mg/kg/day of S ... LLC).: Results: Treatment of mice with 3 mg/kg/day of S-pindolol in KPC or LLC cancer cachexia ...

Abstract	Background: It is known that S-pindolol attenuates muscle loss in animal models of cancer cachexia and sarcopenia. In cancer cachexia, it also significantly reduced mortality and improved cardiac function, which is strongly compromised in cachectic animals. Methods: Here, we tested 3 mg/kg/day of S-pindolol in two murine cancer cachexia models: pancreatic cancer cachexia (KPC) and Lewis lung carcinoma (LLC). Results: Treatment of mice with 3 mg/kg/day of S-pindolol in KPC or LLC cancer cachexia models significantly attenuated the loss of body weight, including lean mass and muscle weights, leading to improved grip strength compared with placebo-treated mice. In the KPC model, treated mice lost less than half of the total weight lost by placebo (-0.9 ± 1.0 vs. -2.2 ± 1.4 g for S-pindolol and placebo, respectively, P < 0.05) and around a third of the lean mass lost by tumour-bearing controls (-0.4 ± 1.0 vs. -1.5 ± 1.5 g for S-pindolol and placebo, respectively, P < 0.05), whereas loss of fat mass was similar. In the LLC model, the gastrocnemius weight was higher in sham (108 ± 16 mg) and S-pindolol tumour-bearing (94 ± 15 mg) mice than that in placebo (83 ± 12 mg), whereas the soleus weight was only significantly higher in the S-pindolol-treated group (7.9 ± 1.7 mg) than that in placebo (6.5 ± 0.9). Grip strength was significantly improved by S-pindolol treatment (110.8 ± 16.2 vs. 93.9 ± 17.1 g for S-pindolol and placebo, respectively). A higher grip strength was observed in all groups; whereas S-pindolol-treated mice improved by 32.7 ± 18.5 g, tumour-bearing mice only show minimal improvements (7.3 ± 19.4 g, P < 0.01). Conclusions: S-pindolol is an important candidate for clinical development in the treatment of cancer cachexia that strongly attenuates loss of body weight and lean body mass. This was also seen in the weight of individual muscles and resulted in higher grip strength.
MeSH term(s)	Mice ; Animals ; Cachexia/drug therapy ; Cachexia/etiology ; Cachexia/pathology ; Lung Neoplasms/complications ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Muscle, Skeletal/pathology ; Carcinoma, Lewis Lung/complications ; Carcinoma, Lewis Lung/drug therapy ; Carcinoma, Lewis Lung/pathology ; Pancreas/pathology
Language	English
Publishing date	2023-05-02
Publishing country	Germany
Document type	Journal Article
ZDB-ID	2586864-0
ISSN	2190-6009 ; 2190-5991
ISSN (online)	2190-6009
ISSN	2190-5991
DOI	10.1002/jcsm.13249
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Pregnancy health in a multi-state U.S. population of systemically underserved patients and their children: PROMISE cohort design and baseline characteristics.

Boone-Heinonen, Janne / Lyon-Scott, Kristin / Springer, Rachel / Schmidt, Teresa / Vesco, Kimberly K / Booman, Anna / Dinh, Dang / Fortmann, Stephen P / Foster, Byron A / Hauschildt, Jenny / Liu, Shuling / O'Malley, Jean / Palma, Amy / Snowden, Jonathan M / Stratton, Kalera / Tran, Sarah

BMC public health

2024 Volume 24, Issue 1, Page(s) 886

Abstract: Background: Gestational weight gain (GWG) is a routinely monitored aspect of pregnancy health, yet critical gaps remain about optimal GWG in pregnant people from socially marginalized groups, or with pre-pregnancy body mass index (BMI) in the lower or ... ...

Abstract	Background: Gestational weight gain (GWG) is a routinely monitored aspect of pregnancy health, yet critical gaps remain about optimal GWG in pregnant people from socially marginalized groups, or with pre-pregnancy body mass index (BMI) in the lower or upper extremes. The PROMISE study aims to determine overall and trimester-specific GWG associated with the lowest risk of adverse birth outcomes and detrimental infant and child growth in these underrepresented subgroups. This paper presents methods used to construct the PROMISE cohort using electronic health record data from a network of community-based healthcare organizations and characterize the cohort with respect to baseline characteristics, longitudinal data availability, and GWG. Methods: We developed an algorithm to identify and date pregnancies based on outpatient clinical data for patients 15 years or older. The cohort included pregnancies delivered in 2005-2020 with gestational age between 20 weeks, 0 days and 42 weeks, 6 days; and with known height and adequate weight measures needed to examine GWG patterns. We linked offspring data from birth records and clinical records. We defined study variables with attention to timing relative to pregnancy and clinical data collection processes. Descriptive analyses characterize the sociodemographic, baseline, and longitudinal data characteristics of the cohort, overall and within BMI categories. Results: The cohort includes 77,599 pregnancies: 53% had incomes below the federal poverty level, 82% had public insurance, and the largest race and ethnicity groups were Hispanic (56%), non-Hispanic White (23%) and non-Hispanic Black (12%). Pre-pregnancy BMI groups included 2% underweight, 34% normal weight, 31% overweight, and 19%, 8%, and 5% Class I, II, and III obesity. Longitudinal data enable the calculation of trimester-specific GWG; e.g., a median of 2, 4, and 6 valid weight measures were available in the first, second, and third trimesters, respectively. Weekly rate of GWG was 0.00, 0.46, and 0.51 kg per week in the first, second, and third trimesters; differences in GWG between BMI groups were greatest in the second trimester. Conclusions: The PROMISE cohort enables characterization of GWG patterns and estimation of effects on child growth in underrepresented subgroups, ultimately improving the representativeness of GWG evidence and corresponding guidelines.
MeSH term(s)	Pregnancy ; Child ; Female ; Humans ; Infant, Newborn ; Vulnerable Populations ; Obesity/epidemiology ; Overweight/epidemiology ; Gestational Weight Gain ; Pregnancy Trimester, Third ; Body Mass Index ; Pregnancy Complications/epidemiology ; Pregnancy Outcome/epidemiology
Language	English
Publishing date	2024-03-23
Publishing country	England
Document type	Journal Article
ZDB-ID	2041338-5
ISSN	1471-2458 ; 1471-2458
ISSN (online)	1471-2458
ISSN	1471-2458
DOI	10.1186/s12889-024-18257-8
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: The Chitranjan S. Ranawat Award: Manipulation Under Anesthesia to Treat Postoperative Stiffness After Total Knee Arthroplasty: A Multicenter Randomized Clinical Trial.

Abdel, Matthew P / Salmons, Harold I / Larson, Dirk R / Austin, Matthew S / Barnes, C Lowry / Bolognesi, Michael P / Della Valle, Craig J / Dennis, Douglas A / Garvin, Kevin L / Geller, Jeffrey A / Incavo, Stephen J / Lombardi, Adolph V / Peters, Christopher L / Schwarzkopf, Ran / Sculco, Peter K / Springer, Bryan D / Pagnano, Mark W / Berry, Daniel J

The Journal of arthroplasty

2024

Abstract: Background: Manipulation under anesthesia (MUA) occurs in 4% of patients after total knee arthroplasty (TKA). Anti-inflammatory medications may target arthrofibrosis pathogenesis, but the data are limited. This multicenter randomized clinical trial ... ...

Abstract	Background: Manipulation under anesthesia (MUA) occurs in 4% of patients after total knee arthroplasty (TKA). Anti-inflammatory medications may target arthrofibrosis pathogenesis, but the data are limited. This multicenter randomized clinical trial investigated the effect of adjuvant anti-inflammatory medications with MUA and physical therapy on range of motion (ROM) and outcomes. Methods: There were 124 patients (124 TKAs) who developed stiffness after primary TKA for osteoarthritis enrolled across 15 institutions. All received MUA when ROM was < 90° at 4 to 12 weeks postoperatively. Randomization proceeded via a permuted block design. Controls received MUA and physical therapy, while the treatment group also received one dose of pre-MUA intravenous dexamethasone (8 mg) and 14 days of oral celecoxib (200 mg). The ROM and clinical outcomes were assessed at 6 weeks and 1 year. This trial was registered with ClinicalTrials.gov. Results: The ROM significantly improved a mean of 46° from a pre-MUA ROM of 72 to 118° immediately after MUA (P < .001). The ROM was similar between the treatment and control groups at 6 weeks following MUA (101 versus 99°, respectively; P = .35) and at one year following MUA (108 versus 108°, respectively; P = .98). Clinical outcomes were similar at both end points. Conclusions: In this multicenter randomized clinical trial, the addition of intravenous dexamethasone and a short course of oral celecoxib after MUA did not improve ROM or outcomes. However, MUA provided a mean ROM improvement of 46° immediately, 28° at 6 weeks, and 37° at 1 year. Further investigation in regards to dosing, duration, and route of administration of anti-inflammatory medications remains warranted. Level of evidence: Level 1, RCT.
Language	English
Publishing date	2024-02-27
Publishing country	United States
Document type	Journal Article
ZDB-ID	632770-9
ISSN	1532-8406 ; 0883-5403
ISSN (online)	1532-8406
ISSN	0883-5403
DOI	10.1016/j.arth.2024.02.034
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2134: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.

Yuan, Luping / Springer, Jochen / Palus, Sandra / Busquets, Silvia / Jové, Queralt / Alves de Lima Junior, Edson / Anker, Markus S / von Haehling, Stephan / Álvarez Ladrón, Natalia / Millman, Oliver / Oosterlee, Annemijn / Szymczyk, Agata / López-Soriano, Francisco Javier / Anker, Stefan D / Coats, Andrew J S / Argiles, Josep M

Journal of cachexia, sarcopenia and muscle

2022 Volume 14, Issue 1, Page(s) 653–660

Abstract: Background: Beta-blockers and selected stereoisomers of beta-blockers, like bisoprolol and S ... hepatoma rat cancer cachexia model and compared with placebo, 50 mg/kg/d S-oxprenolol (HR: 0.49, 95% CI: 0 ... that had a significant effect on body weight loss in the S-oxprenolol groups vs the same combination ...

Abstract	Background: Beta-blockers and selected stereoisomers of beta-blockers, like bisoprolol and S-pindolol (ACM-001), have been shown to be effective in preclinical cancer cachexia models. Here, we tested the efficacy of stereoisomers of oxprenolol in two preclinical models of cancer cachexia-the Yoshida AH-130 rat model and the Lewis lung carcinoma (LLC) mouse model. Methods and results: In the Yoshida AH130 hepatoma rat cancer cachexia model and compared with placebo, 50 mg/kg/d S-oxprenolol (HR: 0.49, 95% CI: 0.28-0.85, P = 0.012) was superior to 50 mg/kg/d R-oxprenolol (HR: 0.83, 95% CI 0.38-1.45, P = 0.51) in reducing mortality (= reaching ethical endpoints). Combination of the three doses (12.5, 25 and 50 mg/kg/d) that had a significant effect on body weight loss in the S-oxprenolol groups vs the same combination of the R-oxprenolol groups lead to a significantly improved survival of S-oxprenolol vs R-oxprenolol (HR: 1.61, 95% CI: 1.08-2.39, P = 0.0185). Interestingly, there is a clear dose dependency in S-oxprenolol-treated (5, 12.5, 25 and 50 mg/kg/d) groups, which was not observed in groups treated with R-oxprenolol. A dose-dependent attenuation of weight and lean mass loss by S-oxprenolol was seen in the Yoshida rat model, whereas R-oxprenolol had only had a significant effect on fat mass. S-oxprenolol also non-significantly reduced weight loss in the LLC model and also improved muscle function (grip strength 428 ± 25 and 539 ± 37 g/100 g body weight for placebo and S-oxprenolol, respectively). However, there was only a minor effect on quality of life indicators food intake and spontaneous activity in the Yoshida model (25 mg/kg/S-oxprenolol: 11.9 ± 2.5 g vs placebo: 4.9 ± 0.8 g, P = 0.013 and also vs 25 mg/kg/d R-oxprenolol: 7.5 ± 2.6 g, P = 0.025). Both enantiomers had no effects on cardiac dimensions and function at the doses used in this study. Western blotting of proteins involved in the anabolic/catabolic homoeostasis suggest that anabolic signalling is persevered (IGF-1 receptor, Akt) and catabolic signalling is inhibited (FXBO-10, TRAF-6) by S-pindolol, but not he R-enantiomer. Expression of glucose transporters Glut1 and Glut 4 was similar in all groups, as was AMPK. Conclusions: S-oxprenolol is superior to R-oxprenolol in cancer cachexia animal models and shows promise for a human application in cancer cachexia.
MeSH term(s)	Mice ; Rats ; Humans ; Animals ; Cachexia/drug therapy ; Cachexia/etiology ; Cachexia/metabolism ; Oxprenolol/therapeutic use ; Rats, Wistar ; Quality of Life ; Rats, Inbred Lew ; Adrenergic beta-Antagonists/therapeutic use ; Liver Neoplasms ; Pindolol
Chemical Substances	Oxprenolol (519MXN9YZR) ; ACM-001 COVID-19 vaccine ; Adrenergic beta-Antagonists ; Pindolol (BJ4HF6IU1D)
Language	English
Publishing date	2022-11-08
Publishing country	Germany
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2586864-0
ISSN	2190-6009 ; 2190-5991
ISSN (online)	2190-6009
ISSN	2190-5991
DOI	10.1002/jcsm.13116
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Assessing rodents as carriers of pathogenic Leptospira species in the U.S. Virgin Islands and their risk to animal and public health.

Scientific reports

2022 Volume 12, Issue 1, Page(s) 1132

Abstract: ... We sought to determine if rodents in U.S. Virgin Islands (USVI) are carriers of Leptospira. In total, 140 ...

Abstract	Leptospirosis is a global zoonotic disease caused by pathogenic bacteria of the genus Leptospira. We sought to determine if rodents in U.S. Virgin Islands (USVI) are carriers of Leptospira. In total, 140 rodents were sampled, including 112 Mus musculus and 28 Rattus rattus. A positive carrier status was identified for 64/140 (45.7%); 49 (35.0%) were positive by dark-field microscopy, 60 (42.9%) by culture, 63 (45.0%) by fluorescent antibody testing, and 61 (43.6%) by real-time polymerase chain reaction (rtPCR). Molecular typing indicated that 48 isolates were L. borgpetersenii and 3 were L. kirschneri; the remaining nine comprised mixed species. In the single culture-negative sample that was rtPCR positive, genotyping directly from the kidney identified L. interrogans. Serotyping of L. borgpetersenii isolates identified serogroup Ballum and L. kirschneri isolates as serogroup Icterohaemorrhagiae. These results demonstrate that rodents are significant Leptospira carriers and adds to understanding the ecoepidemiology of leptospirosis in USVI.
MeSH term(s)	Animals ; Carrier State/diagnosis ; Carrier State/epidemiology ; Carrier State/microbiology ; Carrier State/transmission ; Disease Reservoirs/microbiology ; Female ; Humans ; Leptospira/genetics ; Leptospira/isolation & purification ; Leptospirosis/epidemiology ; Leptospirosis/microbiology ; Leptospirosis/transmission ; Leptospirosis/veterinary ; Male ; Mice ; Molecular Typing ; Public Health ; Rats ; United States Virgin Islands/epidemiology ; Zoonoses
Language	English
Publishing date	2022-01-21
Publishing country	England
Document type	Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, U.S. Gov't, P.H.S.
ZDB-ID	2615211-3
ISSN	2045-2322 ; 2045-2322
ISSN (online)	2045-2322
ISSN	2045-2322
DOI	10.1038/s41598-022-04846-3
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes.

Kathayat, Rahul S / Cao, Yang / Elvira, Pablo D / Sandoz, Patrick A / Zaballa, María-Eugenia / Springer, Maya Z / Drake, Lauren E / Macleod, Kay F / van der Goot, F Gisou / Dickinson, Bryan C

Nature communications

2018 Volume 9, Issue 1, Page(s) 334

Abstract: The reversible modification of cysteine residues by thioester formation with palmitate (S ... palmitoylation) is an abundant lipid post-translational modification (PTM) in mammalian systems. S-palmitoylation ... metabolic lipids and mitochondrial regulation. However, it is unknown whether and/or how mitochondrial S ...

Abstract	The reversible modification of cysteine residues by thioester formation with palmitate (S-palmitoylation) is an abundant lipid post-translational modification (PTM) in mammalian systems. S-palmitoylation has been observed on mitochondrial proteins, providing an intriguing potential connection between metabolic lipids and mitochondrial regulation. However, it is unknown whether and/or how mitochondrial S-palmitoylation is regulated. Here we report the development of mitoDPPs, targeted fluorescent probes that measure the activity levels of "erasers" of S-palmitoylation, acyl-protein thioesterases (APTs), within mitochondria of live cells. Using mitoDPPs, we discover active S-depalmitoylation in mitochondria, in part mediated by APT1, an S-depalmitoylase previously thought to reside in the cytosol and on the Golgi apparatus. We also find that perturbation of long-chain acyl-CoA cytoplasm and mitochondrial regulatory proteins, respectively, results in selective responses from cytosolic and mitochondrial S-depalmitoylases. Altogether, this work reveals that mitochondrial S-palmitoylation is actively regulated by "eraser" enzymes that respond to alterations in mitochondrial lipid homeostasis.
MeSH term(s)	A549 Cells ; Acyl Coenzyme A/metabolism ; Fluorescent Dyes/metabolism ; HEK293 Cells ; HeLa Cells ; Humans ; Kinetics ; Lipoylation ; MCF-7 Cells ; Microscopy, Confocal ; Mitochondria/metabolism ; Mitochondrial Dynamics ; RNA Interference ; Thiolester Hydrolases/genetics ; Thiolester Hydrolases/metabolism
Chemical Substances	Acyl Coenzyme A ; Fluorescent Dyes ; LYPLA1 protein, human (EC 3.1.2.-) ; Thiolester Hydrolases (EC 3.1.2.-)
Language	English
Publishing date	2018-01-23
Publishing country	England
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	2553671-0
ISSN	2041-1723 ; 2041-1723
ISSN (online)	2041-1723
ISSN	2041-1723
DOI	10.1038/s41467-017-02655-1
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Assessing rodents as carriers of pathogenic Leptospira species in the U.S. Virgin Islands and their risk to animal and public health

Scientific Reports, Vol 12, Iss 1, Pp 1-

2022 Volume 10

Abstract: ... Leptospira. We sought to determine if rodents in U.S. Virgin Islands (USVI) are carriers of Leptospira ...

Abstract	Abstract Leptospirosis is a global zoonotic disease caused by pathogenic bacteria of the genus Leptospira. We sought to determine if rodents in U.S. Virgin Islands (USVI) are carriers of Leptospira. In total, 140 rodents were sampled, including 112 Mus musculus and 28 Rattus rattus. A positive carrier status was identified for 64/140 (45.7%); 49 (35.0%) were positive by dark-field microscopy, 60 (42.9%) by culture, 63 (45.0%) by fluorescent antibody testing, and 61 (43.6%) by real-time polymerase chain reaction (rtPCR). Molecular typing indicated that 48 isolates were L. borgpetersenii and 3 were L. kirschneri; the remaining nine comprised mixed species. In the single culture-negative sample that was rtPCR positive, genotyping directly from the kidney identified L. interrogans. Serotyping of L. borgpetersenii isolates identified serogroup Ballum and L. kirschneri isolates as serogroup Icterohaemorrhagiae. These results demonstrate that rodents are significant Leptospira carriers and adds to understanding the ecoepidemiology of leptospirosis in USVI.
Keywords	Medicine ; R ; Science ; Q
Language	English
Publishing date	2022-01-01T00:00:00Z
Publisher	Nature Portfolio
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: A qualitative analysis of the social and cultural contexts that shape screen time use in Latino families living on the U.S.-Mexico border.

Barroso, Cristina S / Springer, Andrew E / Ledingham, Christopher M / Kelder, Steven H

International journal of qualitative studies on health and well-being

2020 Volume 15, Issue 1, Page(s) 1735766

Abstract: ... ...

Abstract	Purpose
MeSH term(s)	Adolescent ; Adult ; Child ; Culture ; Decision Making ; Emigrants and Immigrants ; Family Relations/ethnology ; Female ; Focus Groups ; Hispanic Americans ; Humans ; Male ; Parents/psychology ; Screen Time ; United States/ethnology
Language	English
Publishing date	2020-02-14
Publishing country	United States
Document type	Journal Article
ZDB-ID	2232726-5
ISSN	1748-2631 ; 1748-2623
ISSN (online)	1748-2631
ISSN	1748-2623
DOI	10.1080/17482631.2020.1735766
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Distribution of Borrelia burgdorferi s.l. and Borrelia miyamotoi in Ixodes tick populations in Northern Germany, co-infections with Rickettsiales and assessment of potential influencing factors.

Knoll, S / Springer, A / Hauck, D / Schunack, B / Pachnicke, S / Fingerle, V / Strube, C

Medical and veterinary entomology

2021 Volume 35, Issue 4, Page(s) 595–606

Abstract: To determine Borrelia spp. (Spirochaetales: Spirochaetaceae) prevalence and species distribution in Northern Germany, Ixodes ticks were sampled from April to October in 2018 and 2019 by the flagging method at three locations each in five regions. ... ...

Abstract	To determine Borrelia spp. (Spirochaetales: Spirochaetaceae) prevalence and species distribution in Northern Germany, Ixodes ticks were sampled from April to October in 2018 and 2019 by the flagging method at three locations each in five regions. Analysis by quantitative real-time PCR of 3150 individual ticks revealed an overall prevalence of 30.6%, without significant differences between tick stages (31.7% positive adults, 28.6% positive nymphs). Significant differences were observed in seasonal infection rates, but not between regions, landscape types or sampling years. Analysis of co-infections with Rickettsiales indicated a negative association between Borrelia and Anaplasma phagocytophilum infection. The most frequent Borrelia species differentiated by Reverse Line Blot were B. afzelii and B. garinii/B. bavariensis, followed by B. valaisiana, B. burgdorferi sensu stricto, B. spielmanii and B. lusitaniae. Furthermore, B. miyamotoi was identified in 12.9% of differentiable samples. No effect of region nor landscape type on species composition was found, but significant variations in the distribution at the different sampling sites within a region were observed. The detected monthly fluctuations in prevalence and the differences in intra-regional Borrelia species distribution underline the importance of long-term and multi-location monitoring of Borrelia spp. in ticks as an essential part of public health assessment.
MeSH term(s)	Animals ; Borrelia ; Borrelia burgdorferi ; Borrelia burgdorferi Group ; Coinfection/epidemiology ; Coinfection/veterinary ; Germany/epidemiology ; Ixodes ; Rickettsiales
Language	English
Publishing date	2021-06-27
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	286021-1
ISSN	1365-2915 ; 0269-283X
ISSN (online)	1365-2915
ISSN	0269-283X
DOI	10.1111/mve.12537
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 3067: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: The European Union’s anti-money laundering and countering the financing of terrorism (AML/CFT) draft list and Caribbean realities

Springer, Sandra

The Round Table

Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #639143
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

To top

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Kategorien

Inter-library loan at ZB MED